Isolation and characterization of the primary epithelial breast cancer cells and the adjacent normal epithelial cells from Iranian women’s breast cancer tumors

[1]  R. Smith,et al.  Breast cancer epidemiology. , 2018 .

[2]  Soheil Saadat,et al.  Incidence of primary breast cancer in Iran: Ten-year national cancer registry data report. , 2015, Cancer epidemiology.

[3]  C. Mathers,et al.  Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 , 2015, International journal of cancer.

[4]  P. Vineis,et al.  Global cancer patterns: causes and prevention , 2014, The Lancet.

[5]  S. Roberts,et al.  Isolation and Characterisation of Mesenchymal Stem Cells from Different Regions of the Human Umbilical Cord , 2013, BioMed research international.

[6]  A. Weaver,et al.  Human Calmodulin-Like Protein CALML3: A Novel Marker for Normal Oral Squamous Mucosa That Is Downregulated in Malignant Transformation , 2013, International journal of dentistry.

[7]  Shahpar Haghighat,et al.  Survival Rate of Breast Cancer Based on Geographical Variation in Iran, a National Study , 2012, Iranian Red Crescent medical journal.

[8]  F. Salvatore,et al.  Cytometric and biochemical characterization of human breast cancer cells reveals heterogeneous myoepithelial phenotypes , 2012, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[9]  Mohamad Amin Pourhoseingholi,et al.  Increased trend of breast cancer mortality in Iran. , 2012, Asian Pacific journal of cancer prevention : APJCP.

[10]  M. Espié,et al.  Immunohistochemical and molecular analyses of HER2 status in breast cancers are highly concordant and complementary approaches , 2011, British Journal of Cancer.

[11]  F. Lupu,et al.  Differential regulation of human and murine P-selectin expression and function in vivo , 2010, The Journal of experimental medicine.

[12]  C. Mathers,et al.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.

[13]  S. Schnitt,et al.  Mapping the cellular and molecular heterogeneity of normal and malignant breast tissues and cultured cell lines , 2010, Breast Cancer Research.

[14]  S. Coughlin,et al.  Breast cancer as a global health concern. , 2009, Cancer epidemiology.

[15]  O. Tetsu,et al.  Genetic Profiling Reveals Cross-Contamination and Misidentification of 6 Adenoid Cystic Carcinoma Cell Lines: ACC2, ACC3, ACCM, ACCNS, ACCS and CAC2 , 2009, PloS one.

[16]  Paolo Romano,et al.  Cell Line Data Base: structure and recent improvements towards molecular authentication of human cell lines , 2008, Nucleic Acids Res..

[17]  Dirk Hasenclever,et al.  Prognostic Effect of Epithelial Cell Adhesion Molecule Overexpression in Untreated Node-Negative Breast Cancer , 2008, Clinical Cancer Research.

[18]  M. Ringnér,et al.  The CD44+/CD24- phenotype is enriched in basal-like breast tumors , 2008, Breast Cancer Research.

[19]  Thomas D. Schmittgen,et al.  Analyzing real-time PCR data by the comparative CT method , 2008, Nature Protocols.

[20]  O. Gires,et al.  Glycosylation is crucial for stability of tumour and cancer stem cell antigen EpCAM. , 2008, Frontiers in bioscience : a journal and virtual library.

[21]  Carlos Caldas,et al.  Alpha‐6 integrin is necessary for the tumourigenicity of a stem cell‐like subpopulation within the MCF7 breast cancer cell line , 2008, International journal of cancer.

[22]  R. Beroukhim,et al.  Molecular definition of breast tumor heterogeneity. , 2007, Cancer cell.

[23]  I. Nagtegaal,et al.  Loss of membranous Ep-CAM in budding colorectal carcinoma cells , 2007, Modern Pathology.

[24]  G. Sherlock,et al.  The prognostic role of a gene signature from tumorigenic breast-cancer cells. , 2007, The New England journal of medicine.

[25]  Wen-Lin Kuo,et al.  A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes. , 2006, Cancer cell.

[26]  H. Moch,et al.  Overexpression of epithelial cell adhesion molecule (Ep-CAM) is an independent prognostic marker for reduced survival of patients with epithelial ovarian cancer. , 2006, Gynecologic oncology.

[27]  N. Kapucuoglu,et al.  CD24 expression in ductal carcinoma in situ and invasive ductal carcinoma of breast: an immunohistochemistry-based pilot study. , 2006, Pathology, research and practice.

[28]  M Vasei,et al.  Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers , 2006, British Journal of Cancer.

[29]  A. Ashworth,et al.  CD24 staining of mouse mammary gland cells defines luminal epithelial, myoepithelial/basal and non-epithelial cells , 2005, Breast Cancer Research.

[30]  S. Lim CD24 and human carcinoma: tumor biological aspects. , 2005, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[31]  P. Tan,et al.  Immunohistochemical detection of Ki67 in breast cancer correlates with transcriptional regulation of genes related to apoptosis and cell death , 2005, Modern Pathology.

[32]  David Botstein,et al.  Different gene expression patterns in invasive lobular and ductal carcinomas of the breast. , 2004, Molecular biology of the cell.

[33]  A. Bielawska,et al.  The ceramide analog, B13, induces apoptosis in prostate cancer cell lines and inhibits tumor growth in prostate cancer xenografts , 2004, The Prostate.

[34]  I. Nagtegaal,et al.  The epithelial cell adhesion molecule (Ep-CAM) as a morphoregulatory molecule is a tool in surgical pathology. , 2003, The American journal of pathology.

[35]  R. Tibshirani,et al.  Repeated observation of breast tumor subtypes in independent gene expression data sets , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[36]  Y. Le Marchand-Brustel,et al.  Reduced activation of phosphatidylinositol-3 kinase and increased serine 636 phosphorylation of insulin receptor substrate-1 in primary culture of skeletal muscle cells from patients with type 2 diabetes. , 2003, Diabetes.

[37]  B. Wollenberg,et al.  Tumor-specific glycosylation of the carcinoma-associated epithelial cell adhesion molecule EpCAM in head and neck carcinomas. , 2003, Cancer letters.

[38]  S. Morrison,et al.  Prospective identification of tumorigenic breast cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[39]  G. Kristiansen,et al.  Tumour Biological Aspects of CD24, A Mucin-Like Adhesion Molecule , 2003, Journal of Molecular Histology.

[40]  J. R. Reeves,et al.  Evaluating HER2 amplification and overexpression in breast cancer , 2001, The Journal of pathology.

[41]  B. Rosner,et al.  Measurement error correction in nutritional epidemiology based on individual foods, with application to the relation of diet to breast cancer. , 2001, American journal of epidemiology.

[42]  J W Gamel,et al.  Non-parametric comparison of relative versus cause-specific survival in Surveillance, Epidemiology and End Results (SEER) programme breast cancer patients , 2001, Statistical methods in medical research.

[43]  J. Hopper,et al.  Genetic epidemiology of female breast cancer. , 2001, Seminars in cancer biology.

[44]  R. Tibshirani,et al.  Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[45]  J. Johanson Critical review of the epidemiology of gastroesophageal reflux disease with specific comparisons to asthma and breast cancer. , 2001, The American journal of gastroenterology.

[46]  E. Strehler,et al.  The Tumor-sensitive Calmodulin-like Protein Is a Specific Light Chain of Human Unconventional Myosin X* , 2001, The Journal of Biological Chemistry.

[47]  Christian A. Rees,et al.  Molecular portraits of human breast tumours , 2000, Nature.

[48]  C. Watson,et al.  A novel cell culture model for studying differentiation and apoptosis in the mouse mammary gland , 2000, Breast Cancer Research.

[49]  M. Foley,et al.  Loss of immunoreactivity for human calmodulin-like protein is an early event in breast cancer development. , 1999, Neoplasia.

[50]  A. Green,et al.  Short-term primary culture of epithelial cells derived from human breast tumours. , 1998, British Journal of Cancer.

[51]  P. Altevogt,et al.  CD24, a mucin-type glycoprotein, is a ligand for P-selectin on human tumor cells. , 1997, Blood.

[52]  R. Cote,et al.  Antigen Retrieval Immunohistochemistry: Past, Present, and Future , 1997, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[53]  A. Green,et al.  A comparative study of cytokine gene transcripts in normal and malignant breast tissue and primary cell cultures derived from the same tissue samples , 1996, International journal of cancer.

[54]  H. Schulman,et al.  Selective activation and inhibition of calmodulin-dependent enzymes by a calmodulin-like protein found in human epithelial cells. , 1994, European journal of biochemistry.

[55]  R. Tarone,et al.  Involution and the etiology of breast cancer , 1994, Cancer.

[56]  J. Cox,et al.  Cation binding and conformation of human calmodulin-like protein. , 1993, Biochemistry.

[57]  K. Namboodiri,et al.  Breast cancer risk: effects of estrogen replacement therapy and body mass. , 1993, Journal of the National Cancer Institute.

[58]  I. Henderson Risk factors for breast cancer development , 1993, Cancer.

[59]  J. Cox,et al.  Characterization of the human calmodulin-like protein expressed in Escherichia coli. , 1992, Biochemistry.

[60]  Sam W. Lee,et al.  Down-regulation of a member of the S100 gene family in mammary carcinoma cells and reexpression by azadeoxycytidine treatment. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[61]  P. Yaswen,et al.  Down-regulation of a calmodulin-related gene during transformation of human mammary epithelial cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[62]  E. Lane,et al.  Keratin expression in human mammary epithelial cells cultured from normal and malignant tissue: relation to in vivo phenotypes and influence of medium. , 1989, Journal of cell science.

[63]  V. Band,et al.  Distinctive traits of normal and tumor-derived human mammary epithelial cells expressed in a medium that supports long-term growth of both cell types. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[64]  S. L. Hammond,et al.  Serum-free growth of human mammary epithelial cells: rapid clonal growth in defined medium and extended serial passage with pituitary extract. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[65]  M. Herlyn,et al.  Colorectal carcinoma-specific antigen: detection by means of monoclonal antibodies. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[66]  M. S. Steinberg,et al.  Contact inhibitions of overlapping and differential cell adhesion: a sufficient model for the control of certain cell culture morphologies. , 1974, Journal of cell science.

[67]  L. Sachs,et al.  In Vitro Cell Transformation with Chemical Carcinogens , 1963, Nature.

[68]  A. Jemal,et al.  Cancer statistics, 2016 , 2016, CA: a cancer journal for clinicians.

[69]  T. Sebo,et al.  Human calmodulin-like protein (CLP) expression in oral squamous mucosa and in malignant transformation. , 2009, Journal of prosthodontics : official journal of the American College of Prosthodontists.

[70]  H. Hameister,et al.  Localization of the intronless gene coding for calmodulin-like protein CLP to human chromosome 10p13-ter , 2004, Human Genetics.

[71]  S. Ethier,et al.  Isolation and Culture of Human Breast Cancer Cells from Primary Tumors and Metastases , 2000 .

[72]  M J Bissell,et al.  Cellular changes involved in conversion of normal to malignant breast: importance of the stromal reaction. , 1996, Physiological reviews.

[73]  P. Kincade,et al.  CD44 and its interaction with extracellular matrix. , 1993, Advances in immunology.

[74]  J. Peterson Animal Cell Culture: A Practical Approach , 1993, The Yale Journal of Biology and Medicine.

[75]  K. Ebeling,et al.  [Epidemiology of breast cancer]. , 1988, Archiv fur Geschwulstforschung.